期刊文献+

脑梗死患者氯吡格雷抵抗及其与90天时血管事件的相关性 被引量:13

Association between clopidogrel resistance and ischemic vascular events in cerebral infarction patients on day 90 after treatment
下载PDF
导出
摘要 目的探讨用氯吡格雷的脑梗死患者氯吡格雷抵抗(CR)发生率,CR与90d时脑梗死复发及其他血管事件的相关性。方法 515例脑梗死患者服氯吡格雷前和7-10d后,测血小板聚集率,筛选CR 203例(CR组)及氯吡格雷敏感(CS组)312例,患者出院后仍服氯吡格雷,随访90d。原发终点为缺血性血管事件复合终点,次要终点为改良的Rankin量表(mRS)评分。logistic回归分析CR发生的危险因素,Cox比例风险分析缺血性血管事件发生的危险因素。结果糖尿病(OR=2.36,95%CI:1.24-4.98,P=0.00)是CR发生的独立危险因素。随访期,CR组总缺血性血管事件(12.3%vs 4.8%)和脑梗死复发率高于CS组(8.4%vs 1.9%);mRS评分0-2分比例低于CS组(67.5%vs 79.8%,P〈0.01)。CR(RR=2.88,95%CI:1.28-6.92,P=0.00)、糖尿病(RR=1.59,95%CI:1.02-3.48,P=0.00)、高血压(RR=1.86,95%CI:1.16-4.69,P=0.00)是缺血性血管事件发生的独立危险因素。结论用氯吡格雷脑梗死患者CR发生率高,CR与缺血性血管事件、脑梗死复发和神经功能恢复密切相关。 Objective To study the association between clopidogrel resistance(CR)and ischemic vascular events in cerebral infarction patients on day 90 after treatment.Methods The platelet aggregation rate was assayed in 515 cerebral infarction patients before and 7-10days after clopidogrel treatment.The patients were divided into CR group(n=203)and clopidogrel sensitive(CS)group(n=312).The patients going on clopidogrel treatment after discharge were followed up for 90 days.The primary endpoint was a composite endpoint of ischemic vascular events,the second endpoint was the mRS score on day 90 after treatment.The risk factors for CR and ischemic vascular events were analyzed by logistic regression analysis and Cox proportional model respectively.Results Diabetes mellitus(DM)was the independent risk factor for CR(OR=2.36,95%CI:1.24-4.98,P=0.00).The incidence of ischemic vascular events and recurrent cerebral infarction was significantly higher whereas the mRS score(0-2)was significantly lower in CR group than in CS group.CR,DM,and hypertension were the risk factors for ischemic vascular events(RR=2.88,95%CI:1.28-6.92,P=0.00;RR=2.36,95%CI:1.24-4.98,P=0.00;RR=1.86,95%CI:1.16-4.69,P=0.00).Conclusion The incidence of CR is high in cerebral infarction patients after clopidogrel treatment.CR is closely associated with ischemic vascular events,recurrent cerebral infarction and restored neurological function.
出处 《中华老年心脑血管病杂志》 CAS 2016年第8期841-844,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 德阳市重点科学技术研究项目(2014SZ035)
关键词 脑梗死 复发 血小板聚集 动脉粥样硬化 阿司匹林 brain infarction recurrence platelet aggregation atherosclerosis aspirin
  • 相关文献

参考文献16

  • 1Ferreiro JL,Bhatt DL,Ueno M,et al.Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin orclopidogrel:insights from the CAPRIE trial(clopidogrel versus aspirin in patients at risk of ischemic events).J Am Coll Cardiol,2014,63:769-777.
  • 2Silva FB,Almeida Junior GL,Neno A,et al.Resistance to clopidogrel:prevalence and associate variables.Arq Bras Cardiol,2012,99:1135-1141.
  • 3Topuoglu MA,Arsava EM,Ay H.Antiplatelet resistance in stroke.Expert Rev Neurother,2011,11:251-263.
  • 4Rho GJ,Shin WR,Kong TS,et al.Significance of clopidogrel resistance related to the stent-assisted angioplasty in patients with atherosclerotic cerebrovascular disease.J Korean Neurosurg Soc,2011,50:40-44.
  • 5Szapáry L,Koltai K,Tibold A,et al.Clopidogrel resistance in cerebrovascular disease--results of one-year follow-up.Orv Hetil,2015,156:53-59.
  • 6Han SW,Kim SH,Lee JY,et al.A new subtype classification of ischemic stroke based on treatment and etiologic mechanism.Eur Neurol,2007,57:96-102.
  • 7易兴阳,苏微微,林静,池丽芬,池万章.脑梗死二级预防中阿司匹林抵抗及其与血管事件的关系[J].中华神经科杂志,2011,44(6):375-378. 被引量:36
  • 8Shuldiner AR,OConnell JR,Bliden KP,et al.Association of cytochrome P450 2C19genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.JAMA,2009,302:849-857.
  • 9Depta JP,Fowler J,Novak E,et al.Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.Stroke,2012,43:2376-2381.
  • 10Wang L,Wang XB,Chen FH.Clopidogrel resistance is associated with long-term thrombotic events in patients implanted with drug-eluting stents.Drugs R D,2010,10:219-224.

二级参考文献3

共引文献35

同被引文献105

引证文献13

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部